VIVUS is a pharmaceutical company that specializes in developing and commercializing novel therapeutic products, including therapies to address obesity, sleep apnea, diabetes, and male sexual health. Qnexa, the company’s lead investigational product, has completed phase 3 clinical trials for treating obesity and is currently being considered for approval in the U.S. and E.U. Other VIVUS products are currently at various trial and approval stages. For more information, visit the company’s Web site at www.volcanocorp.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: